A Stage IV leiomyosarcoma survivor who translated checkpoint inhibitor research into patient-accessible language. The book circulates across Amazon, eBay, ThriftBooks, and international platforms — but there is no owned hub, no email capture, and no organic content footprint. Amazon controls the reader relationship. Here is what the data shows.
Four metrics that define the current digital footprint. Three gaps and one lane that nobody in the space has claimed.
The entities that dominate immunotherapy and cancer patient-education search results. None of them combine personal survivor voice with institutional sourcing credibility — that lane is open.
| Platform / Author | Organic Keywords | Traffic Value | Voice / Positioning |
|---|---|---|---|
| Cancer Research Institute | 8,612 | $235K/mo | Institutional org — no personal survivor voice |
| American Cancer Society | Large org | Dominant | Institutional org — no personal voice |
| The Patient Story | Growing | Mid-range | First-person stories platform — not a single author voice |
| Cancer Support Community | Established | Mid-range | Support org — no survivor-author credibility |
| Lynne Meredith | ~0 | $0/mo | Survivor author + institutional sourcing — no owned channel yet |
Three things must be in place before any organic content, community, or outreach effort converts. Here is the architecture.
Ad platforms restrict health-condition targeting. But organic survivor storytelling on short-form video faces none of those restrictions — and the leiomyosarcoma community is tight-knit and underserved. Here is the channel-first sequence we would run.
A 20-minute call is all it takes. We will walk through every finding and tell you exactly what we would do first.
Book a 20-Minute Call